Literature DB >> 18501846

Antimycobacterial therapy for Crohn's disease: a reanalysis.

Marcel A Behr, James Hanley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18501846     DOI: 10.1016/S1473-3099(08)70104-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  11 in total

1.  Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states.

Authors:  William Richard Berrington; Murdo Macdonald; Saraswoti Khadge; Bishwa Raj Sapkota; Marta Janer; Deanna Alisa Hagge; Gilla Kaplan; Thomas Richard Hawn
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

2.  Anti-Mycobacterium paratuberculosis (MAP) therapy for Crohn's disease: an overview and update.

Authors:  Sailish Honap; Emma Johnston; Gaurav Agrawal; Bahij Al-Hakim; John Hermon-Taylor; Jeremy Sanderson
Journal:  Frontline Gastroenterol       Date:  2020-07-28

3.  Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease.

Authors:  Gaurav Agrawal; Thomas Borody; Robert Turner; Sharyn Leis; Jordana Campbell
Journal:  Future Sci OA       Date:  2015-09-28

4.  Is Mycobacterium avium paratuberculosis the Trigger in the Crohn's Disease Spectrum?

Authors:  Harry A Oken; Paul G Saleeb; Robert R Redfield; Stephen C Schimpff
Journal:  Open Forum Infect Dis       Date:  2017-05-18       Impact factor: 3.835

5.  Profound remission in Crohn's disease requiring no further treatment for 3-23 years: a case series.

Authors:  Gaurav Agrawal; Annabel Clancy; Roy Huynh; Thomas Borody
Journal:  Gut Pathog       Date:  2020-04-09       Impact factor: 4.181

6.  A rhodanine agent active against non-replicating intracellular Mycobacterium avium subspecies paratuberculosis.

Authors:  Tim J Bull; Richard Linedale; Jason Hinds; John Hermon-Taylor
Journal:  Gut Pathog       Date:  2009-12-23       Impact factor: 4.181

7.  Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario.

Authors:  John Hermon-Taylor
Journal:  Gut Pathog       Date:  2009-07-14       Impact factor: 4.181

8.  The Consensus from the Mycobacterium avium ssp. paratuberculosis (MAP) Conference 2017.

Authors:  J Todd Kuenstner; Saleh Naser; William Chamberlin; Thomas Borody; David Y Graham; Adrienne McNees; John Hermon-Taylor; Amy Hermon-Taylor; C Thomas Dow; Walter Thayer; James Biesecker; Michael T Collins; Leonardo A Sechi; Shoor Vir Singh; Peilin Zhang; Ira Shafran; Stuart Weg; Grzegorz Telega; Robert Rothstein; Harry Oken; Stephen Schimpff; Horacio Bach; Tim Bull; Irene Grant; Jay Ellingson; Heinrich Dahmen; Judith Lipton; Saurabh Gupta; Kundan Chaubey; Manju Singh; Prabhat Agarwal; Ashok Kumar; Jyoti Misri; Jagdip Sohal; Kuldeep Dhama; Zahra Hemati; William Davis; Michael Hier; John Aitken; Ellen Pierce; Nicole Parrish; Neil Goldberg; Maher Kali; Sachin Bendre; Gaurav Agrawal; Robert Baldassano; Preston Linn; Raymond W Sweeney; Marie Fecteau; Casey Hofstaedter; Raghava Potula; Olga Timofeeva; Steven Geier; Kuruvilla John; Najah Zayanni; Hoda M Malaty; Christopher Kahlenborn; Amanda Kravitz; Adriano Bulfon; George Daskalopoulos; Hazel Mitchell; Brett Neilan; Verlaine Timms; Davide Cossu; Giuseppe Mameli; Paul Angermeier; Tomislav Jelic; Ralph Goethe; Ramon A Juste; Lauren Kuenstner
Journal:  Front Public Health       Date:  2017-09-27

9.  Targeted Combination Antibiotic Therapy Induces Remission in Treatment-Naïve Crohn's Disease: A Case Series.

Authors:  Gaurav Agrawal; Annabel Clancy; Rijata Sharma; Roy Huynh; Sanjay Ramrakha; Thomas Borody
Journal:  Microorganisms       Date:  2020-03-06

Review 10.  Putting Crohn's on the MAP: Five Common Questions on the Contribution of Mycobacterium avium subspecies paratuberculosis to the Pathophysiology of Crohn's Disease.

Authors:  Gaurav Agrawal; John Aitken; Harrison Hamblin; Michael Collins; Thomas J Borody
Journal:  Dig Dis Sci       Date:  2020-10-22       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.